EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY 4.0

Prospective external validation of radiomics‐based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non‐small‐cell lung cancer: A multi‐institutional analysis

Takanori Adachi iD, Mitsuhiro Nakamura, Yukinori Matsuo iD, Katsuyuki Karasawa, Masaki Kokubo, Takashi Sakamoto, Masahiro Hiraoka, Takashi Mizowaki iD

Journal of Applied Clinical Medical Physics · 2024

DOI: 10.1002/acm2.14475 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Applied Clinical Medical Physics, 2024. Verfasst von Takanori Adachi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Radiosurgery, Lung Neoplasms, Radiotherapy Dosage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose This study aims to externally validate a predictive model for distant metastasis (DM) with computed tomography (CT)‐based radiomics features in prospectively enrolled non‐small‐cell lung cancer patients undergoing dynamic tumor‐tracking stereotactic body radiation therapy (DTT‐SBRT). Materials and methods The study collected retrospective data from 567 patients across 11 institutions as the training dataset and prospectively enrolled 42 patients from four institutions as the external test dataset. Four clinical features were collected, and 944 CT‐based radiomic features were extracted from gross tumor volumes. After standardization and feature selection, DM predictive models were developed using fine and gray regression (FG) and random survival forest (RSF), incorporating clinical and radiomic features, and their combinations within the training dataset. Then, the model was applied to the test dataset, dividing patients into high‐ and low‐risk groups based on medians of risk scores. Model performance was assessed using the concordance index ( C ‐index), and the statistical significance between groups was evaluated using Gray's test.

Results

In the training dataset, 122 of 567 patients (21.5%) developed DM, compared to 9 of 42 patients (21.4%) in the test dataset. In the test dataset, the C‐indices of the clinical, radiomics, and hybrid models with FG were 0.559, 0.544, and 0.560, respectively, whereas those with RSF were 0.576, 0.604, and 0.627, respectively. The hybrid model with RSF, which exhibited the best predictive performance of all models, identified 7 of 23 patients (30.4%) as high risk and 2 of 19 patients (10.5%) as low risk for DM incidence in the test dataset ( p = 0.116).

Conclusion

Although predictive models for DM lack significance when applied to prospectively enrolled cases undergoing DTT‐lung SBRT, the model with RSF exhibits a consistent capacity to effectively classify patients at a high risk of developing DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungRadiosurgeryLung NeoplasmsRadiotherapy DosageTomography, X-Ray ComputedHumansMaleFemaleProspective StudiesAgedMiddle AgedRetrospective StudiesRadiotherapy Planning, Computer-AssistedRadiotherapy, Intensity-ModulatedAged, 80 and overPrognosisNeoplasm MetastasisAdultImage Processing, Computer-AssistedRadiomics

Stichwörter der Autor:innen

distant metastasisdynamic tumor trackinglung SBRTmulti‐institutional studyprognostic predictionprospective external validationradiomics

Autor:innen und Institutionen

  • Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Division of Radiation Oncology, Department, of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Department of Radiation Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Department of Radiation Oncology, Kyoto Katsura Hospital, Kyoto, Japan.
  • Department of Radiation Oncology, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan.

ORCID-Profile: Takanori Adachi, Yukinori Matsuo, Takashi Mizowaki

Zitieren

APA

Adachi, T., Nakamura, M., Matsuo, Y., Karasawa, K., Kokubo, M., Sakamoto, T., Hiraoka, M., & Mizowaki, T. (2024). Prospective external validation of radiomics‐based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non‐small‐cell lung cancer: A multi‐institutional analysis. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14475

Vancouver

Adachi T, Nakamura M, Matsuo Y, Karasawa K, Kokubo M, Sakamoto T, et al. Prospective external validation of radiomics‐based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non‐small‐cell lung cancer: A multi‐institutional analysis. Journal of Applied Clinical Medical Physics. 2024. doi:10.1002/acm2.14475

BibTeX
@article{Adachi2024,
  author = {Adachi, Takanori and Nakamura, Mitsuhiro and Matsuo, Yukinori and Karasawa, Katsuyuki and Kokubo, Masaki and Sakamoto, Takashi and Hiraoka, Masahiro and Mizowaki, Takashi},
  title = {Prospective external validation of radiomics‐based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non‐small‐cell lung cancer: A multi‐institutional analysis},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2024},
  doi = {10.1002/acm2.14475}
}
Kostenlos starten →